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Notch1 Expression in Early Lymphopoiesis
Influences B versus T Lineage Determination
1991; Weinmaster et al., 1991, 1992; Lardelli et al., 1994;
Uyttendaele et al., 1996). Mammalian Notch signaling is
initiated by binding of one of a series of ligands that are
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also transmembrane proteins, such as Jagged1 (LindsellJon C. Aster,4 and Warren S. Pear1,5
et al., 1995), Jagged2 (Shawber et al., 1996; Luo et al.,1Department of Pathology and Laboratory Medicine
1997), or Delta (Bettenhausen et al., 1995; Dunwoodieand Institute of Medicine and Engineering
et al., 1997). Ligand binding is believed to lead to a2Department of Genetics
series of proteolytic cleavages that result in transportUniversity of Pennsylvania Medical Center
of the intracellular domains of Notch to the nucleus,Philadelphia, Pennsylvania 19104
where Notch behaves as a transcriptional activator (Le-3Fox Chase Cancer Center
courtois and Schweisguth, 1998; Schroeter et al., 1998;Philadelphia, Pennsylvania 19111
Struhl and Adachi, 1998). One important downstream4Department of Pathology
target of Notch is a transcription factor, variably knownBrigham and Women's Hospital
as Suppressor of Hairless [Su(H)] in invertebrates andHarvard Medical School
CBF1/RBP-Jk in mammals, which is activated by NotchBoston, Massachusetts 02115
binding (Jarriault et al., 1995; Eastman et al., 1997). The
targets of activated CBF1/RBP-Jk are incompletely
characterized but include the Hairy Enhancer of SplitSummary
(HES) genes, which are upregulated by Notch and which
in turn downregulate the activity of certain HLH tran-Notch receptors regulate fate decisions in many cells.
scription factors (Jennings et al., 1994; Bailey and Posa-One outcome of Notch signaling is differentiation of
kony, 1995; Lecourtois and Schweisguth, 1995).bipotential precursors into one cell type versus an-
Hematopoiesis involves multiple fate decisions thatother. To investigate consequences of Notch1 expres-
result in the production of diverse hematolymphoidsion in hematolymphoid progenitors, mice were re-
cells from multipotent hematopoietic stem cells (HSCs)constituted with bone marrow (BM) transduced with
(Aguila et al., 1997). Lineage specification and maturationretroviruses encoding a constitutively active form of
from HSCs is tightly regulated and proceeds in discreteNotch1. Although neither granulocyte or monocyte dif-
steps that are dependent on both cellular interactionsferentiation were appreciably affected, lymphopoiesis
and soluble factors. The molecular mechanisms thatwas dramatically altered. As early as 3 weeks follow-
regulate cell fate specification from HSCs are incom-ing transplantation, mice receiving activated Notch1-
pletely understood. Consistent with its functions in in-transduced BM contained immature CD41CD81 T cells
vertebrates, Notch is postulated to play one of two rolesin the BM and exhibited a simultaneous block in early B
in hematopoiesis; it may maintain cells in a less differen-
cell lymphopoiesis. These results suggest that Notch1
tiated state and thus provide a pool of less mature cells
provides a key regulatory signal in determining T that can be recruited when necessary, or it may specify
lymphoid versus B lymphoid lineage decisions, possi- one of two alternative cell fates from a bipotential pro-
bly by influencing lineage commitment from a common genitor (Milner and Bigas, 1999). A role for Notch1 in
lymphoid progenitor cell. maintaining a pool of less differentiated cells is sug-
gested by its expression in CD341 human HSCs (Milner
Introduction et al., 1994) and by in vitro experiments demonstrating
that Notch signaling can prevent or delay myeloid differ-
Notch genes encode a highly conserved family of trans- entiation (Milner et al., 1996; Jones et al., 1998; Varnum-
membrane receptors that regulate the progression of Finney et al., 1998; Carlesso et al., 1999). A role for
cells from an undifferentiated to a differentiated state Notch1 signaling in binary cell fate decisions is sug-
gested by in vivo results in which Notch1 expressionas well as the cell fate decisions made at branchpoints
influences ab versus gd T cell fate as well as CD4 versusbetween distinct developmental pathways (Robey, 1997;
CD8 ab T cell fate (Robey et al., 1996; Washburn et al.,Fleming, 1998; Greenwald, 1998). Proteins encoded
1997). However, since Notch12/2 mouse embryos die atby Notch genes are large type 1 transmembrane gly-
11.5 days postcoitum (Swiatek et al., 1994; Conlon etcoprotein receptors composed of a series of iterated
al., 1995), in vivo experiments demonstrating Notch1structural motifs, including epidermal growth factor±like
regulation of HSC differentiation are lacking.repeats that have been implicated in ligand binding and
To determine whether Notch1-mediated signals in-intracellular ankyrin-like repeats that are required for
fluence hematopoietic lineage decisions in hemato-downstream signaling events. Four mammalian Notch
poietic progenitor cells, we performed bone marrowhomologs (Notch1±4) have been identified (Ellisen et al.,
transplantation (BMT) with progenitor cells transduced
with Notch1-expressing retroviral vectors. Our previous
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studies showed that despite multi-lineage expression,mail.med.upenn.edu).
retroviral-directed expression of activated Notch1 re-6 These authors contributed equally to this work.
sulted in the exclusive development of T cell leukemia/7Present address: Abramson Cancer Center, University of Pennsyl-
vania, Philadelphia, Pennsylvania 19104. lymphoma between 77 and 280 days following BMT
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Figure 1. ICN1 Expression Correlates with
GFP Expression in Cells Transduced with Mig
ICN1
(A) Diagrams of the retroviral constructs used
to transduce murine BM cells. MigR1 is an
MSCV-based retrovirus with an internal ribo-
somal entry site (IRES) and GFP sequence
insert (Pear et al., 1998). Mig ICN1 encodes
the intracellular domain of hNotch1. Mig
DANK encodes ICN1 with a deletion of the
ANK region.
(B) Flow cytometric analysis of FL5.12 cells
72 hr after transduction with MigR1 or Mig
ICN1. The upper row is the level of GFP ex-
pression in nonpermeabilized cell popula-
tions. The lower row is intracellular staining
for Notch1 using a polyclonal antibody raised
against the Tc region of ICN1. The intensity
of GFP expression is reduced by the perme-
abilization/fixation procedure. These results
are representative of four experiments. Ab-
breviations: RAM, RAM23 domain; N1 and
N2, nuclear localization sequences; ANK, an-
kyrin repeats; Tc, C-terminal transactivation
domain.
(Pear et al., 1996). To determine the influence of Notch1 as a surrogate marker for ICN1 and DANK expression
(Figure 1B). ICN1 expression in FL5.12 cells was furtherexpression in hematopoietic development, we studied
the effect of Notch1 expression in bone marrow (BM) confirmed by Western blotting with the anti-Tc antibody
(data not shown).progenitor cells as early as 18 days following BMT.
These studies show that constitutive expression of acti-
vated Notch1 results in the emergence of a population
of thymic-independent T cells in the bone marrow, con- Activated Notch1 Does Not Influence Granulocyte
or Macrophage Maturationcurrent with an early and persistent block in B cell matu-
ration. In contrast to its profound effects on lymphoid BM cells, enriched for HSCs, were obtained from
5-fluorouracil treated BALB/c mice, transduced ex vivodevelopment, constitutive Notch1 signaling did not af-
fect myeloid maturation. with each retroviral construct, and then transplanted
into lethally irradiated syngeneic mice (Pear et al., 1998).
Resultant chimeric mice were subsequently sacrificedResults
at various timepoints following BMT, and cells from BM,
spleen, and thymus were analyzed by flow cytometry,An In Vivo Assay to Determine the Role of Activated
Notch1 in Hematopoiesis using GFP expression to identify transduced cells
(GFP1). Myeloid differentiation in the BM was assessedcDNAs encoding either the intracellular domain of hu-
man Notch1, ICN1 (Pear et al., 1996), or a form of ICN1 at day 18 following BMT using Mac-1 and Gr-1 staining
(Figure 2A). Mature granulocytes and macrophageslacking the ankyrin-like repeat (ANK) region, DANK
(Aster et al., 1997), were cloned into MigR1, a vector were present in approximately equal numbers in the
GFP2 and GFP1 BM populations of the MigR1 and Migthat permits coexpression of cloned cDNAs and green
fluorescent protein (GFP) from a single bicistronic mes- ICN1 mice. Similarly, the numbers of GFP1Gr11Mac11
cells in splenic suspensions did not differ significantlysage (Figure 1A) (Pear et al., 1998). ICN1 encodes the
intracellular domain of Notch1, which consists of the between MigR1 and Mig ICN1 animals at day 18
post-BMT (Figure 2B). GFP1 myeloid cells in Mig ICN1ANK repeats flanked by two nuclear localization se-
quences (N1 and N2), an N-terminal RAM domain (Roehl cells expressed elevated levels of Notch1 protein that
were similar to the level of Notch1 protein in theet al., 1996), and C-terminal transactivation (Tc) (Kuro-
oka et al., 1998) and PEST domains. Retrovirally ex- GFP1CD41CD81 BM population described below (Fig-
ure 2C). Examination of the BM, spleens, and peripheralpressed ICN1 localizes to the nucleus and is constitu-
tively active (Pear et al., 1996; Aster et al., 1997). blood of other chimeric mice up to day 40 following
BMT also failed to show an effect of ICN1 expression onIntracellular staining of Mig ICN1±transduced FL5.12
cells with a polyclonal antibody raised against the Tc myeloid differentiation (data not shown). These results
suggest that ICN1 expression does not dramatically af-region of Notch1 confirmed that GFP expression corre-
lated with ICN1 expression, validating the use of GFP fect myeloid differentiation.
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Figure 2. ICN1 Expression Does Not Alter Myeloid Differentiation
(A) Flow cytometric analysis of BM from BALB/c mice 18 days after receiving syngeneic BM transduced with MigR1 (top panels) or Mig ICN1
(bottom panels). The mice were divided into transduced and nontransduced populations based on GFP expression. The staining antibodies
are indicated adjacent to each axis. The numbers indicate the percentage of cells within each quadrant. Fewer than 1% of the day 18 Mig
ICN1 GFP1 BM or GFP1 spleen cells coexpressed CD4 and/or CD8. B cell reconstitution had not occurred in either the MigR1 or Mig ICN1
mice at day 18 (data not shown). The percentages in this figure as well as in Figures 3 and 4 are the relative percentages of the indicated
gates.
(B) Comparison of Gr11Mac11 cells in the GFP1 populations of MigR1 and Mig ICN1 BM and spleen at day 18 following BM transfer. Proportions
of GFP1 cells in the Gr11Mac11 fraction in MigR1 (white bars) and Mig ICN1 (black bars) mice in BM and spleen. Two mice (1 and 2) receiving
BM transduced with each virus were analyzed.
(C) Notch1 is expressed in GFP1 myeloid cells. Flow cytometric analysis of BM from BALB/c mice 80 days after receiving syngeneic BM
transduced with MigR1 (left panel) or Mig ICN1 (three right panels). Cells were purified based on either GFP and CD11b/Mac1 expression or
GFP and CD4, CD8 expression as indicated above each histogram. The cells were permeabilized and stained with either an anti-Notch1
antibody plus secondary (white) or the secondary phycoerythrin (PE)-conjugated goat-anti-rabbit monoclonal antibody alone (gray shading).
The anti-Notch signal is shown on log scale on the abscissa, and the number of cells is shown in linear scale on the ordinate.
Activated Notch1 Causes the Appearance of Thymic- identified mice in which the GFP1Thy1.21CD41CD81 T
cell population coexpressed intermediate levels of bothIndependent T Cells in the Bone Marrow
Unlike myeloid lineage differentiation, ICN1 expression CD3 and TCRab (data not shown). None of the chimeric
mice, including the MigR1 or DANK mice, containedhad a profound and reproducible effect on T and B
lymphopoiesis. Examination of the BM from Mig ICN1 GFP1 cells in the thymus at this time point (Figure 3A).
Analysis of additional ICN1 mice at day 23 postBMTmice sacrificed 22±23 days following BMT revealed the
presence of a GFP1Thy1.21CD81 T cell population identified a mouse whose BM cell population contained
appro ximately 50% GFP1Thy1.21CD41CD81 cells.showing variable levels of CD4 coexpression that com-
prised between 0.9% and 12.7% of the GFP1 BM frac- Southern blot analysis of DNA obtained from the BM
cells of this animal showed several TCRb gene re-tion (Figures 3A and 3B; data not shown). This popula-
tion was not present in the GFP2 fraction of the Mig arrangements of varying intensity, consistent with the
presence of an oligoclonal T cell population (Figure 3C).ICN1 mice or in the GFP1 and GFP2 BM fractions of the
MigR1 and Mig DANK mice. For the mice analyzed in Similar oligoclonal TCRb rearrangements were also ob-
served in other Mig ICN animals at early timepointsFigures 3A and 3B, the Mig ICN1±specific BM T cell pop-
ulation was CD252CD442CD242CD32 and did not ex- postBMT (22±28 days), whereas TCRb rearrangements
were not detected in the BM cells of MigR1 control micepress either surface TCRab or TCRgd (data not shown).
Analysis of additional Mig ICN1 mice at later timepoints (Figure 3C; data not shown).
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Figure 3. ICN1 Expression Causes the Appearance of an Immature T Cell Population in the Bone Marrow
(A) GFP expression in BM and thymus 22±23 days after receiving syngeneic BM transduced with MigR1, Mig ICN1, or Mig DANK. The regions
used to determine the GFP2 and GFP1 cell populations are shown.
(B) Flow cytometric analysis of BM from BALB/c mice 22±23 days after receiving syngeneic BM transduced with MigR1, Mig ICN1, or Mig
DANK. The BM cells were divided into transduced and nontransduced populations based on GFP expression (as shown in A). The results are
representative of five MigR1, six Mig ICN1, and three Mig DANK mice. The staining antibodies are indicated adjacent to each axis. The numbers
are the relative percentages within the indicated gates. Transfer of transduced Ly5.21 BM cells into Ly5.11 recipients has shown that the
CD41 and CD81 single-positive cells that are present in the GFP2 fraction are donor-derived mature cells that have survived 5-fluorouracil
treatment (data not shown).
(C) Oligoclonal TCRb rearrangements are detected at day 23 postBMT in the BM of mice receiving Mig ICN1±transduced BM cells. Arrowheads
indicate the rearranged fragments. DNA size markers are indicated on the right in kilobases. The hybridization probe is the 2.2 kb EcoRI TCR
Jb2-specific DNA fragment (Fenton et al., 1988), which hybridizes to a 5 kb HindIII fragment in unrearranged DNA. Five micrograms of DNA
was loaded in each lane.
The appearance of GFP1 T cells in the BM prior to later B lineage subsets (CD45R1CD432), including sIg1
(CD45R1sIgM1) B cells in both the GFP2 and GFP1 frac-GFP1 cells in the thymus suggested that the differentia-
tion of these cells was thymus independent. To demon- tions (Figure 5A; data not shown). Although these popu-
lations were present in the GFP2 fraction in the BM ofstrate this formally, thymectomized BALB/c mice were
reconstituted with ICN1-transduced BM cells. Analysis the Mig ICN1 mice, they were significantly decreased
in the GFP1 fraction, suggesting a block in proliferationof BM from thymectomized recipients at day 37 following
BMT revealed the presence of a GFP1Thy1.21CD41CD81 or differentiation at an early stage of B cell maturation
(Figure 5A).T cell population that was absent from the GFP2 popula-
tion (Figure 4A; data not shown). In further support of To further clarify the stage of B lineage differentiation
perturbed by Notch activity, we assessed the presencetheir T lineage status, a portion of these cells expressed
low but detectable levels of CD3 (Figure 4B). Thus, acti- of the earliest defined B lineage±committed progenitor
populations in the BM of MigR1 and Mig ICN1 micevated Notch1 promotes thymic-independent T cell de-
velopment in the BM. The high percentage of immature (Hardy et al., 1991; Li et al., 1996; Allman et al., 1999).
Commonly referred to as pre-pro-B cells, these cell pop-T cells in this mouse is likely due to analysis at a later
timepoint following BMT. It is unclear whether the differ- ulations are defined by the cell surface phenotype CD24/
HSA2, CD45R1, and can be distinguished from non-Bence in CD3 expression between this mouse and the
mice analyzed at day 23 is due to natural variation, the lineage CD45R1 cells by their expression of the cell
surface molecule AA4.1 (Li et al., 1996). While the pro-effect of thymectomy, or limited maturation of the BM
T cell population. portions of pre-pro-B cells were not significantly differ-
ent between the GFP2 population of the Mig ICN1 mice
and the GFP2 and GFP1 populations of the MigR1 mice,Activated Notch1 Causes an Early and Persistent
Block in B Cell Differentiation there was a marked decrease in pre-pro-B cells among
GFP1 cells in Mig ICN1 mice (Figure 5B). These dataIf ICN1 is affecting differentiation of a common lymphoid
progenitor, the Notch signaling paradigm predicts that indicate that Notch activity blocks B lymphopoiesis at
or before the generation of pre-pro-B cells. Moreover,the observed T cell hyperplasia would be associated
with B cell hypoplasia. Consistent with this hypothesis, the decrease in the proportions of B lineage progenitor
cells was consistent across all defined B lineage precur-the GFP1 cell population of Mig ICN1 mice showed a
marked defect in B cell reconstitution at day 22±23 post- sor subsets (Figure 5C). Deletion of the ankyrin repeats,
previously shown to be essential for ICN1 signalingBMT (Figure 5). The BM of MigR1 and Mig DANK mice
showed the presence of pro-B cells (CD45R1CD431) and (Lieber et al., 1993; Matsuno et al., 1995; Kurooka et al.,
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there may be a selection bias for mutated or truncated
nonfunctional ICN1 proteins. In summary, these data
suggest that Notch1 activity induces a persistent block
in B cell maturation, rather than a transient delay.
Analysis of the BM, spleen, and thymus for GFP1
T cells was also performed at these later timepoints.
CD41CD81GFP1 T cells were first detected in the spleen
by day 26, trailing their appearance in the BM by several
days. By day 29, these cells accounted for 4%±60% of
the GFP1 fraction in the BM, and by day 40, these cells
constituted the majority of GFP1 cells in the spleen and/
or BM. The level of GFP expression in this T cell popula-
tion was consistently high, and such cells were not de-
tected at any timepoint in the BM or spleen of the MigR1
mice or in the GFP2 fraction of the Mig ICN1 mice.
Between days 65 and 110, all ICN1 mice developed
T cell leukemia, whose phenotype was similar to the
immature CD41CD81GFP1 population initially identified
in the day 22±23 BM cells of ICN1 mice. In some mice,
the leukemic cells expressed CD3 and TCRab. In con-
trast, the MigR1 and Mig DANK mice have remained
healthy for approximately 1 year postBMT.
Because the CD41CD81 T cell population expandedFigure 4. The ICN1-Induced Bone Marrow T Cell Population Is Thy-
mic Independent prior to the onset of thymic reconstitution, we were un-
able to perform a detailed analysis of the effects of(A) Flow cytometric analysis of BM from a thymectomized BALB/c
mouse 37 days after receiving syngeneic BM transduced with ICN1. Notch expression on T cell maturation. However, both
A similar result was obtained in a second thymectomized recipient CD41GFP1 and CD81GFP1 mature T cells were present
(data not shown). in the thymus and peripheral organs of Mig ICN1 mice
(B) CD3 expression in the GFP1 BM and spleen populations in a
by day 65. In the majority of mice analyzed, the single-thymectomized BALB/c mouse 37 days after receiving syngeneic
positive CD4/CD8 ratios in the thymus were similar inBM transduced with ICN1. Anti-CD79b/Igb was used as a hamster
isotype control for anti-CD3. The staining antibodies are indicated the GFP1 and GFP2 fractions of both the Mig ICN1 and
adjacent to each axis. The numbers are the relative percentages MigR1 mice (data not shown).
within the indicated gates.
Activated Notch1 Specifically Inhibits E2A
1998), restored B cell reconstitution in the DANK mice, Transcriptional Activation
indicating that this domain is essential for inhibition of The ICN1-induced effects on B and T lymphopoiesis are
B lymphopoiesis (Figure 5A). Although the mice receiv- reminiscent of the E2A2/2 phenotype, which is charac-
ing BM transduced with Mig DANK did not show a block terized by an early block in B cell maturation and the
in B cell differentiation, these mice consistently had development of immature T cell lymphoma (Bain et al.,
a greater percentage of CD45R1CD432 B cells and 1994, 1997; Zhuang et al., 1994; Yan et al., 1997). These
decreased percentages of both CD45R1CD431 and similar phenotypes suggested that ICN1 might act
CD45R1sIgM1 B cells (Figure 5A; data not shown). through inhibition of E2A (Ordentlich et al., 1998). To
These results suggest that Mig DANK causes a subtle investigate whether ICN1 specifically inhibits E2A or
alteration in B cell differentiation, possibly by interfering causes a more general effect on transcription factors
with Notch function at the CD45R1CD432 stage of matu- required for B cell differentiation, we tested the ability
ration. of ICN1 to inhibit transcriptional activation by E2A, EBF,
B cell reconstitution was also analyzed in MigR1 and and BSAP/PAX5 (Figure 6). Of these three B cell tran-
Mig ICN1 mice at later time points following BMT (Figure scription factors, only E2A was inhibited by ICN1.
5D). For these studies, B cell reconstitution was defined
as the ratio of late B cells (CD45R1CD432; Hardy frac-
Discussiontions D±F) to early B cells (CD45R1CD431; Hardy frac-
tions A±C) in the GFP1 and GFP2 fractions (Hardy et al.,
We have shown that expression of constitutively active1991; Li et al., 1996; Allman et al., 1999). Analysis of the
Notch1 in BM progenitors causes a persistent block inGFP2 fraction in both the ICN1 and MigR1 mice showed
early B cell differentiation and rapid emergence of anthat the ratio of late to early B cells was greater than
immature BM-derived T cell population. The simplestone in 26/27 mice. Likewise, this ratio was greater than
interpretation of the ability of ICN1 to cause B cell hypo-one in the GFP1 fraction of 7/8 MigR1 mice. In contrast,
plasia and T cell hyperplasia is that Notch1 influencesanalysis of the GFP1 fraction in the Mig ICN1 mice
the fate of progeny derived from a BM-derived commonshowed that only 3/19 mice had a ratio of late to early
lymphoid progenitor cell. This is analogous to previouslyB cells that approached one. In 15/19 Mig ICN1 mice,
observed effects in D. melanogaster and C. elegans,there were either no late B cells present or no B lineage
where Notch functions within bipotent progenitors tocells at all. Moreover, the use of GFP intensity as a
repress adoption of a primary cell fate and promotesurrogate marker for Notch activity is likely to underesti-
mate the effect of Notch on B cell development, since adoption of the alternative secondary cell fate (Fleming,
Immunity
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Figure 5. ICN1 Expression Causes an Early Block in B Cell Differentiation
(A) Flow cytometric analysis of BM from BALB/c mice 22±23 days after receiving syngeneic BM transduced with MigR1, Mig ICN1, or Mig
DANK. The BM cells were divided into transduced and nontransduced populations based on GFP expression. The staining antibodies are
indicated adjacent to each axis. The numbers indicate the percentage of gated cells within each boxed region. The results are representative
of five MigR1, six Mig ICN1, and three Mig DANK mice.
(B) ICN1 expression causes a decrease in the earliest B lineage precursor population. Flow cytometric analysis of BM cells from BALB/c mice
22±23 days after receiving syngeneic BM transduced with MigR1 or Mig ICN1. The BM cells were divided into transduced and nontransduced
populations based on GFP expression. Pre-pro-B cells were identified by gating on CD242PI2 cells and examining the percentage of
AA4.11CD45R1 cells (Li et al., 1996). The staining antibodies are indicated adjacent to each axis. The numbers indicate the percentage of
gated cells within each boxed region. The results are representative of five MigR1 and six Mig ICN1 mice.
(C) ICN1 expression causes a decrease in all B cell precursor fractions. Mean proportions of GFP1 cells in various B cell precursor fractions
in MigR1 (white bars) and Mig ICN1 (black bars) mice at day 23 following BMT. The error bar represents one standard deviation and the
number represents the r-value for the difference between the means. Fraction A1/A2 contains pre-pro-B cells; fractions B/C, pro-B cells and
early pre-B cells; fraction D, late pre-B cells; and fractions E/F, mature B cells. Each B lineage subset was quantified with the following
gates: fractions A1/A2 (pre-pro-B cells), HSA2AA4.11CD45R1; fractions B/C (pro-B cells), CD45R1CD431HSAintermediate; fraction D (pre-B cells),
CD45R1CD432IgM-; and fractions E/F (sIg1 B cells), CD45R1sIgM1 (Hardy et al., 1991; Li et al., 1996; Allman et al., 1999). The results are
from five MigR1 mice and six Mig ICN1 mice.
(D) The B cell defect associated with ICN1 expression persists over time. BALB/c mice received BM transduced with MigR1 or Mig ICN1.
MigR1 and Mig ICN1 mice were sacrificed at various days following BM transplantation, and their BM cells analyzed with flow cytometry
using GFP, CD45R, and CD43 antibodies. B cell reconstitution was determined by the ratio of the late B cells (CD45R1CD432, comprising
Hardy fractions D and E) to the early B cells (CD45R1CD431, comprising Hardy fractions A±C) in the GFP1 and GFP2 cell populations. For
each mouse, the B cell ratio within the GFP1 cells (black) is shown adjacent to the B cell ratio within the GFP2 cells (white). An upward triangle
indicates that no late (CD432) cells were detectable by the limits of the assay (1024 cells) so that the late (CD432)/early (CD431) B cell ratio
is less than 0.01. A circle indicates that B cells (CD45R1) were not detectable. All percentages are the relative percentages of the indicated
gates.
1998; Greenwald, 1998). A physiologic role for Notch1 in our model, this pattern of expression suggests that
Notch1 may function to create and maintain a BMin early stages of T cell differentiation is an attractive
possibility, since unlike most other BM-derived cells, T lymphoid progenitor pool that is competent for T cell
differentiation, in part by making such cells refractorycells undergo definitive differentiation at an extramedul-
lary site, the thymus. Analysis of purified murine B cell to environmental cues that drive adoption of alternative
fates.fractions utilizing a sensitive RT±PCR assay for Notch1
expression showed that Notch1 is not expressed in any Our data suggest that Notch1 activity regulates the
B cell versus T cell fate outcome of a common lym-defined B lineage subset in the BM (Hardy Fractions
A±F) (data not shown). In contrast, Notch1 is highly ex- phoid progenitor. These findings complement results
obtained in conditional Notch1 knockout mice (Radtkepressed in immature thymic T cells (Hasserjian et al.,
1996; Washburn et al., 1997). Together with the ability et al., 1999). In this report, lymphocytes from mice
that contained homozygous deletions of Notch1 wereof activated Notch1 to promote T cell differentiation
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Figure 6. ICN1 Expression Abrogates E2A-
Induced Transcriptional Activation but Has
No Effect on BSAP or EBF-Induced Tran-
scriptional Activation
NIH 3T3 cells were transfected with (A) an
[mE51mE21mE3] TATA-Luciferase reporter (5
mg) and E47 (1 mg), and Notch ICN1 (1 mg);
(B) a human CD19 promoter-luciferase re-
porter (8 mg) and murine BSAP/PAX-5 (5 mg),
and Notch ICN1 (5 mg); or (C) a human CD19
promoter-luciferase reporter (5 mg) and hu-
man EBF (5 mg), and Notch ICN1 (5 mg). The
results are the mean of three experiments.
blocked at the earliest stage of T cell development role in later stages of lymphoid differentiation. This is
supported by several findings, which include (1) the ex-(CD251CD442CD42CD82), while there was no block in
pression pattern of Notch2, which is expressed at higherB lymphopoeisis. In contradistinction to our finding that
levels in rat spleen than thymus (Weinmaster et al.,expression of an activated Notch1 transgene caused
1992), (2) expression of Jagged1 in CD45R1 splenocytesectopic T cell development in the bone marrow, the
(Bash et al., 1999), (3) Notch1-induced silencing of CD4thymi of Notch1 knockout mice contained a high propor-
(Kim and Siu, 1998) and its influence on CD4 versustion of mature B cells, suggesting that the absence of
CD8 and ab versus gd T cell lineage determination inNotch1 permitted ectopic B cell development in the
transgenic and knockout mice (Robey et al., 1996; Wash-thymus.
burn et al., 1997), (4) an early block (CD441CD252) in TThe results of our studies, combined with those of
cell development in HES12/2 fetal liver hematopoieticRadtke et al. (1999), suggest that Notch1 provides a
stem cells (Tomita et al., 1999), and (5) the antiapoptoticcritical signal in determining lymphoid fate outcome
effect of Notch1 on double-postitive T cell developmentfrom a common lymphoid progenitor cell. This could
(Deftos et al., 1998; Jehn et al., 1999).occur in vivo in several different ways depending on the
Two lines of evidence suggest that effects of Notch1BM expression patterns of Notch and cognate ligands,
on lymphoid development may be mediated throughwhich are not fully characterized at present. In one
altered E2A function: (1) among several transcriptionscenario, common lymphoid progenitors coexpress-
factors required for B cell differentiation, only E2A func-ing Notch1 and at least one ligand might give rise
tion is antagonized by ICN1; and (2) E2A2/2 mice showto two daughter cells of differing fate, analogous to
a block in B cell differentiation accompanied by develop-the situation during vulvar development in C. elegans
ment of T cell leukemia/lymphoma (Bain et al., 1994,(Greenwald, 1998). Alternatively, common lymphoid pro-
1997; Zhuang et al., 1994; Yan et al., 1997). In contrastgenitors might express only Notch1 and have their fate
to the expansion of T cell progenitors in the bone marrowdetermined by contact with ligand-expressing marrow
induced by ICN1, E2A2/2 mice, as well as knockouts ofcells. Of possible relevance, bone marrow stromal cells
other E2A family members (such as E2±2 or HEB), dohave been shown to express several Notch ligands (Li
not show T cell expansion in the bone marrow (Zhuang
et al., 1998; Milner and Bigas, 1999). In a variation on
et al., 1996; Bain and Murre, 1998). This suggests that
this theme, environmental cues might induce Notch1
the phenotype associated with ICN1 expression in BM
expression in only a subset of common lymphoid pro- cells cannot be fully explained by inhibition of E2A activ-
genitors. The latter two scenarios have Notch1 playing ity. While the ability of Notch1 to inhibit E2A offers a
an inductive role to drive T cell differentiation at the reasonable explanation for the lack of B cells in the
expense of other fates. The normal expression pattern ICN1-transduced population, the basis for the rapid out-
of Notch1, high in early T cell progenitors and very low growth of immature T cells in the BM remains to be
in early B cell progenitors, is compatible with an induc- elucidated. In some cells, activated Notch is pro-prolif-
tive role, as is the observation that constitutively active erative (Berry et al., 1997), while in others, specifically
Notch1 drives early stages of T cell differentiation in CD41CD81 T cells, it is antiapoptotic (Deftos et al., 1998;
a thymic-independent fashion. From this perspective, Jehn et al., 1999). An antiapoptotic effect is consistent
we predict that B cell development from a common with the ability of Notch to inhibit E2A, since forced
lymphoid progenitor in the absence of Notch1 signaling expression of E2A promotes apoptosis in E2A2/2 pre-T
is the default pathway or primary cell fate. In contrast, lymphoma cells (Engel and Murre, 1999). The immaturity
T cell development is the secondary cell fate requiring of the bone marrow T cell population may also reflect
upregulation of the Notch signaling pathway. The failure the ability of ICN1 to inhibit terminal stages of T cell
of most of the marrow-derived T cells expressing acti- differentiation, analogous to the effects of activated
vated Notch1 to mature to CD4 or CD8 single-positive Notch in other vertebrate and invertebrate develop-
T cells may stem from the absence of thymus-specific mental systems (Kopan et al., 1994; Nye et al., 1994;
environmental cues (Carlyle and Zuniga-Pflucker, 1998) Lindsell et al., 1995; Luo et al., 1997; Fleming, 1998;
or from a Notch1-induced block in terminal T cell differ- Greenwald, 1998).
entiation. Our results show that while constitutive Notch1 activ-
Although our data suggest that Notch1 activity directs ity has profound effects on lymphoid differentiation, it
the initial differentiation events from a common lymphoid does not appear to affect myeloid differentiation. Com-
plementary results were observed in the conditionalprogenitor, it is likely that Notch signaling also plays a
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by addition of a 2% paraformaldehyde/0.1% Tween-20 solution forNotch1 knockout mouse model, where the absence of
30 min at room temperature. Following permeabilization, the cellsNotch1 also left myeloid maturation seemingly unaf-
were incubated with either the Notch-specific anti-Tc antibody (Pearfected (Radtke et al., 1999). This is in contrast to previous
et al., 1996) or anti-GST antibody as described (Carlesso et al.,
results suggesting that constitutive Notch1 activity 1999). Cells were washed and incubated with a phycoerythrin (PE)-
blocks or delays myeloid differentiation (Milner et al., conjugated goat-anti-rabbit monoclonal antibody (Sigma) (1 mg/mL).
Flow cytometric analysis was performed using the FACSCalibur1996; Li et al., 1998; Carlesso et al., 1999). The disparity
instrument and CellQuest software (Becton Dickinson). In all experi-in results may be explained, in part, by the assays used
ments, GFP1 cells were defined as the cell population whose GFP-to study myeloid differentiation. The most profound in-
fluorescence intensity was at least one log greater than background.hibitory effects on myeloid differentiation were demon-
This gate was chosen to enrich for the GFP-expressing population
strated in the factor-dependent 32D myeloid cell line, that coexpresses ICN1 or DANK. For the intracellular staining of
where Notch signaling blocked differentiation in re- GFP1 myeloid cells, BM from a mouse receiving either MigR1 or
ICN1-transduced BM cells was stained with biotinylated anti-sponse to some cytokines but not others (Milner et al.,
CD11b/Mac-1 (M1/70) or anti-CD4 (RM4±5) and anti-CD8a (53±6.7)1996; Li et al., 1998). Such an inhibitory effect might be
and revealed with streptavidin Texas red. Following staining, threeobviated in vivo by prodifferentiative signals produced
purified populations (Mac11GFP1; Mac1-GFP2; CD41CD81GFP1)by cell±cell interactions and/or cytokines that are insen-
containing 2 3 104±105 cells were obtained by cell sorting using a
sitive to Notch1-mediated signals. Although constitu- Becton Dickinson FACStar PLUS and stained with either a Notch-
tive Notch1 signaling does not have a marked effect on specific antibody or control following permeabilization as described
above. The intracellularly stained cells were subsequently analyzedthe terminal differentiation of granulocyte and macro-
using a Becton Dickinson FACScan.phages/monocytes, we cannot rule out the possibility
that Notch1 has subtle effects on early myeloid progeni-
tors. The finding that the GFP1AA4.11HSA2CD45R2 Mice and Bone Marrow Transduction
All experiments were conducted in accordance with National Insti-population, containing both lymphoid and myeloid pro-
tutes of Health guidelines for the care and use of animals and withgenitors, is consistently decreased in the BM of Mig
an approved animal protocol from the University of PennsylvaniaICN1 mice raises the possibility that ICN1 may have an
Animal Care and Use Committee. Transduction of BM cells from
effect on early myeloid progenitors (Figure 5B; data not female BALB/c mice (Taconic Farms) with GFP-normalized retroviral
shown). supernatants and transplantation of these cells into lethally irradi-
In addition to our studies on the role of Notch1 in early ated (900R) 4- to 8-week-old female syngeneic recipients was per-
formed as described (Pear et al., 1998). Recipients were sacrificed atevents in hematopoiesis, other work has indicated a role
the indicated time points and single-cell suspensions were preparedfor Notch1 in regulation of ab versus gd and CD4 versus
from BM, spleen, and/or thymus. Red blood cells in BM and splenicCD8 branchpoints at later stages of T cell differentiation,
suspensions were lysed in hypotonic buffer. For experiments using
suggesting that Notch1 may function at multiple T cell thymectomized recipients, thymi were removed from 2-day-old
decision points (Robey et al., 1996; Washburn et al., mice, which were then allowed to mature to 6 weeks of age before
1997). This would not be unexpected, since Notch is irradiation and transplantation with transduced BM.
utilized at multiple successive decision points during
peripheral neurogenesis in Drosophila (Posakony, 1994). Antibodies and Flow Cytometry
In fact, the observed maturation block and expansion For analyses on a Becton Dickinson FACSCalibur equipped with
CellQuest software (Figure 2), BM or spleen cells were stained withof CD41CD81 T cells in our model suggests that Notch
the following reagents purchased from Pharmingen: biotinylatedactivity must be tightly regulated in normal lymphoid
CD11b/Mac-1 (M1/70), CD8a (53±6.7), and CD43 (Ly-48); and PE-development, a possibility supported by the dynamic
conjugated Gr-1 (RB6±8C5), CD4 (RM4±5), and CD45R (RA3±6B2).
pattern of Notch1 expression in normal T cell differentia- Biotinylated antibodies were revealed with streptavidin-CyChrome
tion (Hasserjian et al., 1996). Further work will be needed and dead cells were excluded by staining with TOPRO-III (Molecular
to determine whether the Notch1 effects on lymphoid Probes).
For analyses on a dual-laser Becton Dickinson FACStarPLUSdifferentiation are regulated through interactions be-
equipped with DESK software (Figures 3±5), BM, splenocytes, ortween precursor cells and stromal elements or through
thymocytes were stained with various combinations of the followingcell±cell interactions between equivalent progenitor
antibodies prepared in the laboratory of Dr. R. Hardy: biotinylated
cells. anti-CD8a (Lyt2), anti-CD24/HSA (30F1), and anti-CD45R (RA3±6B2);
PE-conjugated anti-CD3e (500-A2), anti-CD25 (PC-61), anti-CD44
(Pgp-1), anti-IgM (331.31), anti-CD43 (S7), anti-CD79b/Igb (HM-79),Experimental Procedures
and AA4.1; PE-Cy5-conjugated anti-CD24/HSA; and APC-conju-
gated anti-CD4 (GK1.5) and anti-CD45R. Biotinylated antibodiesPlasmids
were revealed with steptavidin Texas red and dead cells excludedMig ICN1 was constructed by subcloning the ICN1 region (codons
with propidium iodide (PI). For computer analyses, all files collected1770±2555) of human Notch1 (hNotch1 or TAN-1) (Pear et al., 1996)
with DESK software were downloaded into the flow cytometry pro-into the BglII site of MigR1 (Pear et al., 1998). Mig DANK was con-
gram FlowJo.structed by cloning ICNDAR (Aster et al., 1997) into the BglII site of
MigR1. ICNDAR, which consists of ICN1 with an internal deletion
removing codons 1858±2206, retains the ability to localize to the Reporter Assay
nucleus by virtue of the amino-terminal nuclear localization se- The following plasmids were used as reporters of transcription acti-
quence in the RAM23 domain (Aster et al., 1997). vation: [E51E21mE3]4 TATA-luciferase to measure the activity of
E47 and CD19 TATA-luciferase to measure the activity of BSAP
and EBF (Kozmik et al., 1992; Carter et al., 1997). CMV-promoterIntracellular Staining
FL5.12 cells were transduced with GFP-normalized retroviral super- plasmids were used to express ICN1, BSAP, or EBF (Adams et al.,
1992; Hagman et al., 1993; Ordentlich et al., 1998). NIH 3T3 cellsnatants obtained following transfection of Bosc23 cells with either
MigR1 or Mig ICN1 (Pear et al., 1993; Pear and Cepko, 1996). Forty- were transfected by calcium phosphate coprecipitation as de-
scribed (Ordentlich et al., 1998) using the amounts of plasmids in-eight hours following transduction, the cells were either directly
analyzed for GFP expression by flow cytometry or permeabilized dicated in the figure legend. Transfections were normalized to
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b-galactosidase activities determined with 100 ng of CMV-b-galacto- Carlesso, N., Aster, J.C., Sklar, J., and Scadden, D.T. (1999). Notch1-
induced delay of human hematopoietic progenitor cell differentiationsidase.
is associated with altered cell cycle kinetics. Blood 93, 838±848.
DNA Analysis Carlyle, J.R., and Zuniga-Pflucker, J.C. (1998). Requirement for the
High±molecular weight DNA was isolated from bone marrow cells, thymus in ab T lymphocyte lineage commitment. Immunity 9,
digested with HindIII, and analyzed by Southern blot hybridization 187±197.
as previously described (Pear et al., 1996). Carter, R.S., Ordentlich, P., and Kadesch, T. (1997). Selective utiliza-
tion of basic helix-loop-helix-leucine zipper proteins at the immuno-
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